WorldCat Linked Data Explorer

Turtle N-Triple JSON-LD RDF/XML HTML Contact Us Home

http://worldcat.org/entity/work/id/1110945702

Annals meeting reports research advances in bipolar disorder and Shwachman-Diamond syndrome

Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome: "Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by pancreatic exocrine insufficiency and bone marrow failure, often associated with neurodevelopmental and skeletal abnormalities. Mutations in the SBDS gene have been shown to cause SDS. The purpose of this document is to provide draft guidelines for diagnosis, evaluation of organ and system abnormalities, and treatment of hematologic, pancreatic, dietary, dental, skeletal, and neurodevelopmental complications. New recommendations regarding diagnosis and management are presented, reflecting advances in understanding the genetic basis and clinical manifestations of the disease based on the consensus of experienced clinicians from Canada, Europe, and the United States. Whenever possible, evidence-based conclusions are made, but as with other rare diseases, the data on SDS are often anecdotal."--P. 40.

Open All Close All

type

about

http://schema.org/about

alternateName

http://schema.org/alternateName

  • "Sixth International Congress on Shwachman-Diamond syndrome"@en
  • "Research advances in bipolar disorder and Shwachman-Diamond syndrome"
  • "Research advances in bipolar disorder and Shwachman-Diamond syndrome"@en
  • "Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome"@en
  • "Annals meeting reports"
  • "Behavioral epigenetics"
  • "Behavioral epigenetics"@en
  • "Advances in bipolar disorder"@en
  • "Second annual pepducin science"
  • "Second annual pepducin science"@en

contributor

http://schema.org/contributor

creator

description

http://schema.org/description

  • "Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome: "Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by pancreatic exocrine insufficiency and bone marrow failure, often associated with neurodevelopmental and skeletal abnormalities. Mutations in the SBDS gene have been shown to cause SDS. The purpose of this document is to provide draft guidelines for diagnosis, evaluation of organ and system abnormalities, and treatment of hematologic, pancreatic, dietary, dental, skeletal, and neurodevelopmental complications. New recommendations regarding diagnosis and management are presented, reflecting advances in understanding the genetic basis and clinical manifestations of the disease based on the consensus of experienced clinicians from Canada, Europe, and the United States. Whenever possible, evidence-based conclusions are made, but as with other rare diseases, the data on SDS are often anecdotal."--P. 40."
  • "Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome: "Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by pancreatic exocrine insufficiency and bone marrow failure, often associated with neurodevelopmental and skeletal abnormalities. Mutations in the SBDS gene have been shown to cause SDS. The purpose of this document is to provide draft guidelines for diagnosis, evaluation of organ and system abnormalities, and treatment of hematologic, pancreatic, dietary, dental, skeletal, and neurodevelopmental complications. New recommendations regarding diagnosis and management are presented, reflecting advances in understanding the genetic basis and clinical manifestations of the disease based on the consensus of experienced clinicians from Canada, Europe, and the United States. Whenever possible, evidence-based conclusions are made, but as with other rare diseases, the data on SDS are often anecdotal."--P. 40."@en
  • "The primary focus of the conference "Application of Combined omics Platforms to Accelerate Biomedical Discovery in Diabesity" was obesity-induced diabetes--diabesity, which covers a constellation of signs, including obesity, insulin resistance, metabolic syndrome, and diabetes. The conference "Prioritizing Health Disparities in Medical Education to Improve Care," held on October 2, 2012, convened medical school faculty and administrators, educators, and students to discuss how to create real solutions to the problem of disparities in health, health quality, and access to health care within the United States at the level of medical schools. On December 4, 2012, the Sackler Institute for Nutrition Science and the New York Academy of Sciences hosted the conference "The Paradox of Overnutrition in Aging and Cognition" to present cutting-edge research that links and investigates overnutrition, aging, and cognition. On September 21, 2012, the Abbott Nutrition Health Institute and the Sackler Institute for Nutrition Science at the New York Academy of Sciences sponsored a conference, "Vitamin D: Beyond Bone," that gathered researchers investigating vitamin D in a wide range of tissues and diseases."@en
  • "Advances in bipolar disorder: "Recently, the 9th International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders--both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD)."--P. 1."
  • "Advances in bipolar disorder: "Recently, the 9th International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders--both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD)."--P. 1."@en
  • ""G protein-coupled receptors (GPCRs) comprise an expanded superfamily of receptors in the human genome. Adhesion class G protein-coupled receptors (adhesion-GPCRs) form the second largest class of GPCRs. Despite the abundance, size, molecular structure, and functions in facilitating cell and matrix contacts in a variety of organ systems, adhesion-GPCRs are by far the most poorly understood GPCR class. The '6th International Adhesion-GPCR Workshop,' held at the Institute of Physiology of the University of Würzburg on September 6-8, 2012, assembled a majority of the investigators currently actively pursuing research on adhesion-GPCRs, including scientists from laboratories in Europe, the United States, and Asia. The meeting featured the nascent mechanistic understanding of the molecular events driving the signal transduction of adhesion-GPCRs, novel models to evaluate their functions, and evidence for their involvement in human disease."
  • "Scientific perspectives on the drive to consume were presented in Ann Arbor, Mich., at the conference entitled "The Interdisciplinary Science of Consumption: Mechanisms of Allocating Resources Across Disciplines." The meeting, which took place May 12-15, 2010 and was sponsored by Rackham Graduate School and the Dept. of Psychology at the University of Michigan, included presentations on human, primate, and rodent models and spanned multiple domains of consumption, including reward seeking, delay discounting, food-sharing reciprocity, and the consumption and display of material possessions across the life span."@en
  • "On March 9, 2012, the New York Academy of Sciences brought together experts representing a variety of perspectives - including academic, industrial, regulatory, as well as those from physicians and consumers - to discuss considerations for the non-biological complex drug (NBCD) regulatory approval pathway, given the emerging regulatory guidelines for biosimilars (follow-on biological complex drugs). Some of the organizers of the conference expressed their belief that NBCDs share a number of characteristic features with biologicals: the structure cannot be fully defined by the available (physicochemical) analytical tests, and quality assurance is based on in-depth knowledge, consistency, and control of the production process. However, their view on NBCDs was not universally accepted among the experts who participated in the conference. Plenary sessions addressed the most recent regulatory developments, experimental design, interchangeability, and immunogenicity issues for follow-on versions of complex drugs from the perspective of key audiences, including industry, regulatory agencies, physicians, and consumers. This report summarizes these various perspectives on NBCDs and the scientific and regulatory considerations associated with complex drug categories."
  • ""This volume presents reports from recent scientific meetings on topics in emerging fields: (1) Diabetes and Oral Disease: Implications for Health Professionals; (2) The New York Stem Cell Foundation: Sixth Annual Translational Stem Cell Research Conference; and (3) Chronic Inflammatory and Neuropathic Pain. "Diabetes and Oral Disease: Implications for Health Professionals" was a one-day conference convened by the Columbia University College of Dental Medicine, the Columbia University College of Physicians and Surgeons, and the New York Academy of Sciences on May 4, 2011 at The New York Academy of Sciences in New York City. The program included an examination of the bidirectional relationship between oral disease and diabetes and the inter-professional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them and ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event. The New York Stem Cell Foundation's "Sixth Annual Translational Stem Cell Research Conference" convened on October 11-12, 2011 at The Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine." Sponsored by The New York Academy of Sciences, MedImmune, and Grünenthal Gmbh, "Chronic Inflammatory and Neuropathic Pain" was a two-day conference June 2-3, 2011 at the New York Academy of Sciences in New York City. Leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies came together at this forum to address novel issues, current challenges, and future directions of basic research in pain and pre-clinical and clinical development of new therapies for chronic pain. Presentations examined recent therapeutic breakthroughs based on small molecules; the emerging role of biologics as potential new therapies; and current challenges and potential solutions for improved translation of new pain therapies following early target identification, pre-clinical modeling, and clinical development"--Academy website."@en
  • ""This volume presents reports from recent scientific meetings on topics in emerging fields: (1) Diabetes and Oral Disease: Implications for Health Professionals; (2) The New York Stem Cell Foundation: Sixth Annual Translational Stem Cell Research Conference; and (3) Chronic Inflammatory and Neuropathic Pain. "Diabetes and Oral Disease: Implications for Health Professionals" was a one-day conference convened by the Columbia University College of Dental Medicine, the Columbia University College of Physicians and Surgeons, and the New York Academy of Sciences on May 4, 2011 at The New York Academy of Sciences in New York City. The program included an examination of the bidirectional relationship between oral disease and diabetes and the inter-professional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them and ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event. The New York Stem Cell Foundation's "Sixth Annual Translational Stem Cell Research Conference" convened on October 11-12, 2011 at The Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine." Sponsored by The New York Academy of Sciences, MedImmune, and Grünenthal Gmbh, "Chronic Inflammatory and Neuropathic Pain" was a two-day conference June 2-3, 2011 at the New York Academy of Sciences in New York City. Leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies came together at this forum to address novel issues, current challenges, and future directions of basic research in pain and pre-clinical and clinical development of new therapies for chronic pain. Presentations examined recent therapeutic breakthroughs based on small molecules; the emerging role of biologics as potential new therapies; and current challenges and potential solutions for improved translation of new pain therapies following early target identification, pre-clinical modeling, and clinical development"--Academy website."
  • "G protein-coupled receptors (GPCRs) comprise an expanded superfamily of receptors in the human genome. Adhesion class G protein-coupled receptors (adhesion-GPCRs) form the second largest class of GPCRs. Despite the abundance, size, molecular structure, and functions in facilitating cell and matrix contacts in a variety of organ systems, adhesion-GPCRs are by far the most poorly understood GPCR class. Adhesion-GPCRs possess a unique molecular structure, with extended N-termini containing various adhesion domains. In addition, many adhesion-GPCRs are autoproteolytically cleaved into an N-terminal fragment (NTF, NT, [alpha]-subunit) and C-terminal fragment (CTF, CT, [beta]-subunit) at a conserved GPCR autoproteolysis-inducing (GAIN) domain that contains a GPCR proteolysis site (GPS). These two features distinguish adhesion-GPCRs from other GPCR classes. Though active research on adhesion-GPCRs in diverse areas, such as immunity, neuroscience, and development and tumor biology has been intensified in the recent years, the general biological and pharmacological properties of adhesion-GPCRs are not well known, and they have not yet been used for biomedical purposes. The "6th International Adhesion-GPCR Workshop," held at the Institute of Physiology of the University of Würzburg on September 6-8, 2012, assembled a majority of the investigators currently actively pursuing research on adhesion-GPCRs, including scientists from laboratories in Europe, the United States, and Asia. The meeting featured the nascent mechanistic understanding of the molecular events driving the signal transduction of adhesion-GPCRs, novel models to evaluate their functions, and evidence for their involvement in human disease."
  • "On March 9, 2012, the New York Academy of Sciences brought together experts representing a variety of perspectives--including academic, industrial, regulatory, as well as those from physicians and consumers--to discuss considerations for the non-biological complex drug (NBCD) regulatory approval pathway, given the emerging regulatory guidelines for biosimilars (follow-on biological complex drugs). Plenary sessions addressed the most recent regulatory developments, experimental design, interchangeability, and immunogenicity issues for follow-on versions of complex drugs from the perspective of key audiences, including industry, regulatory agencies, physicians, and consumers. This report summarizes various perspectives on NBCDs and the scientific and regulatory considerations associated with complex drug categories."
  • ""Recently, the 9th International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders--both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD). At the Sixth International Congress on Shwachman-Diamond Syndrome, held at the New York Academy of Sciences on June 28-30, 2011, researchers from around the world met to discuss the latest clinical and basic science relating to this puzzling condition. Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by pancreatic exocrine insufficiency and bone marrow failure, often associated with neurodevelopmental and skeletal abnormalities. Mutations in the SBDS gene have been shown to cause SDS. The purpose of this document is to provide draft guidelines for diagnosis, evaluation of organ and system abnormalities, and treatment of hematologic, pancreatic, dietary, dental, skeletal, and neurodevelopmental complications. New recommendations regarding diagnosis and management are presented, reflecting advances in understanding the genetic basis and clinical manifestations of the disease based on the consensus of experienced clinicians from Canada, Europe, and the United States. Whenever possible, evidence-based conclusions are made, but as with other rare diseases, the data on SDS are often anecdotal.""
  • "Sixth International Congress on Shwachman-Diamond syndrome: "At the Sixth International Congress on Shwachman-Diamond syndrome, held at the New York Academy of Sciences on June 28-30, 2011, researchers from around the world met to discuss the latest clinical and basic science relating to this puzzling condition."--P. 26."
  • "Sixth International Congress on Shwachman-Diamond syndrome: "At the Sixth International Congress on Shwachman-Diamond syndrome, held at the New York Academy of Sciences on June 28-30, 2011, researchers from around the world met to discuss the latest clinical and basic science relating to this puzzling condition."--P. 26."@en
  • ""This volume presents reports from recent scientific meetings on topics in emerging fields. The program included an examination of the bidirectional relationship between oral disease and diabetes and the inter-professional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them and ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event. The New York Stem Cell Foundation's "Sixth Annual Translational Stem Cell Research Conference" convened on October 11-12, 2011 at The Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine." Sponsored by The New York Academy of Sciences, MedImmune, and Grünenthal Gmbh, "Chronic Inflammatory and Neuropathic Pain" was a two-day conference June 2-3, 2011 at the New York Academy of Sciences in New York City. Leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies came together at this forum to address novel issues, current challenges, and future directions of basic research in pain and pre-clinical and clinical development of new therapies for chronic pain. Presentations examined recent therapeutic breakthroughs based on small molecules; the emerging role of biologics as potential new therapies; and current challenges and potential solutions for improved translation of new pain therapies following early target identification, pre-clinical modeling, and clinical development"--Academy website."
  • ""The conference "Application of Combined 'omics Platforms to Accelerate Biomedical Discovery in Diabesity" was presented by Hot Topics in Life Sciences and the Sackler Institute for Nutrition Science at the New York Academy of Sciences. The conference "Prioritizing Health Disparities in Medical Education to Improve Care" was presented by the Josiah Macy Jr. Foundation, the Associated Medical Schools of New York, the New York University School of Medicine, and the New York Academy of Sciences. The conference "The Paradox of Overnutrition in Aging and Cognition, Precursors of Aging : Facilitating Intervention Strategies" was presented by the Sackler Institute for Nutrition Science at the New York Academy of Sciences. The conference "Vitamin D : Beyond Bone," presented by the Sackler Institute for Nutrition Science at the New York Academy of Sciences, was sponsored by an unrestricted educational grant from Abbott Nutrition Health Institute."--title page."
  • "The Centre for Immunity, Infection and Evolution sponsored a one-day symposium at the University of Edinburgh on 30 June 2011 entitled "Wild Immunology." The central question of the symposium was, "Why should we try to understand infection and immunity in wild systems?" Specifically, how does the immune response operate in the wild and how do multiple coinfections and commensalism affect immune responses and host health in these wild systems?"@en
  • "Sponsored by the New York Academy of Sciences and with support from the National Institute of Mental Health, the Life Technologies Foundation, and the Josiah Macy Jr. Foundation, "Advancing Drug Discovery for Schizophrenia" was held Mar. 9-11, 2011 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, all of which contribute to the overarching goal of enhancing the pharmaceutical armamentarium for treating schizophrenia. This report surveys work by the vanguard of schizophrenia research in such topics as genetic and epigenetic approaches; small molecule therapeutics; and the relationships between target genes, neuronal function, and symptoms of schizophrenia."@en
  • "The "Biomarkers in Nutrition: New Frontiers in Research and Application" conference was held on April 18, 2012 at the New York Academy of Sciences in New York City. The meeting brought together scientists and practitioners from industry, academia, and governmental organizations to discuss the current state of knowledge about nutritional biomarkers, to identify important challenges and unanswered questions, and to catalyze new research toward the common goal of implementing nutritional biomarkers in a broad, cost-effective, and meaningful way. In October 2011, the New York Academy of Sciences hosted a conference entitled "The New Revolution in Toxicology: The Good, Bad and Ugly." A primary goal of this symposium was to advance the discussion by focusing on how differences in broadly applicable new models and technologies for assessing drug efficacy and toxicity might affect choices of appropriate test systems and how those systems would be applied in practice. The "Trans-Pacific Workshop on Stroke" was held at the Wyndham Riverfront Hotel in New Orleans, Louisiana, on October 17-18, 2012. This volume contains a detailed report of the workshop presentations and themes."@en
  • "Sponsored by the New York Academy of Sciences and Cincinnati Children's Hospital Medical Center, with support from the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Drug Abuse (NIDA), and Life Technologies, "Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Preterm Birth" was held on June 11-12, 2012 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, and highlighted the need for specialized testing of drugs, consumer products, and industrial chemicals, with a view to the unique impacts these can have during gestation. Speakers went on to discuss many other factors that affect prenatal development, from genetics to parental diet, revealing the extraordinary sensitivity of the developing fetus."
  • "The "Biomarkers in Nutrition: New Frontiers in Research and Application" conference was held on April 18, 2012 at the New York Academy of Sciences in New York City. The meeting brought together scientists and practitioners from industry, academia, and governmental organizations to discuss the current state of knowledge about nutritional biomarkers, to identify important challenges and unanswered questions, and to catalyze new research toward the common goal of implementing nutritional biomarkers in a broad, cost-effective, and meaningful way. In October 2011, the New York Academy of Sciences hosted a conference entitled "The New Revolution in Toxicology: The Good, Bad and Ugly." A primary goal of this symposium was to advance the discussion by focusing on how differences in broadly applicable new models and technologies for assessing drug efficacy and toxicity might affect choices of appropriate test systems and how those systems would be applied in practice. The "Trans-Pacific Workshop on Stroke" was held at the Wyndham Riverfront Hotel in New Orleans, Louisiana, on October 17-18, 2012. This volume contains a detailed report of the workshop presentations and themes."
  • ""The New York Stem Cell Foundation's "Fifth Annual Translational Stem Cell Research Conference" convened October 12-13, 2010 at the Rockefeller University in New York City. The conference attracted over 400 scientists, patient advocates, and stem cell research supporters from 16 countries. Compiled by young stem cell scientists, this meeting report summarizes the current groundbreaking progress in stem cell research. Sponsored by The New York Academy of Sciences, The Warren Alpert Medical School of Brown University, and The University of Massachusetts, "Behavioral Epigenetics " was held October 29-30, 2010 at the University of Massachusetts Boston Campus Center, Boston, Massachusetts. The conference featured speakers and panel discussions exploring the emerging field of behavioral epigenetics, from basic biochemical and cellular mechanisms to the epigenetic modulation of normative development, developmental disorders, and psychopathology. The meeting report provides an overview of the research presented by leading scientists and lively discussion about the future of investigation at the behavioral epigenetic level. At the Second Pepducin Science Symposium held in Cambridge, Massachusetts in November 2010, investigators working in G protein-coupled receptor GPCR research convened to discuss progress since last year's inaugural conference. This meeting report summarizes the symposium proceedings that focused on increasing knowledge of the structure and function of this ubiquitous superfamily of membrane receptors and their potential modulation for disease treatment, and how GPCR mechanisms might be exploited to treat diseases with pepducins, novel synthetic lipopeptide pharmacophores that modulate heptahelical GPCR activity from inside the cell membrane"--Academy website."@en
  • "^Sponsored by the New York Academy of Sciences and Cincinnati Children's Hospital Medical Center, with support from the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Drug Abuse (NIDA), and Life Technologies, 'Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Preterm Birth' was held on June 11-12, 2012 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, and highlighted the need for specialized testing of drugs, consumer products, and industrial chemicals, with a view to the unique impacts these can have during gestation. Speakers also discussed many other factors that affect prenatal development, from genetics to parental diet, revealing the extraordinary sensitivity of the developing fetus"--Publisher's description."

genre

http://schema.org/genre

  • "Aufsatzsammlung"
  • "Electronic books"
  • "Livre électronique (Descripteur de forme)"
  • "Conference papers and proceedings"
  • "Conference papers and proceedings"@en
  • "Ressource Internet (Descripteur de forme)"
  • "Literaturbericht"

name

http://schema.org/name

  • "Annals Meeting reports"
  • "Annals Meeting Reports"
  • "Annals meeting reports NYSCF Fifth Annual Translational Stem Cell Research Conference: Behavioral epigenetics : second annual pepducin science"
  • "Annals meeting reports (2012 : Annals of the New York Academy of Sciences, volume 1276)"
  • "Annals meeting reports research advances in bipolar disorder and Shwachman-Diamond syndrome"
  • "Annals meeting reports research advances in bipolar disorder and Shwachman-Diamond syndrome"@en
  • "Annals meeting reports"@en
  • "Annals meeting reports"
  • "Annals meeting reports : research advances in bipolar disorder and Shwachman-Diamond syndrome"@en
  • "Annals meeting reports : NYSCF Fifth Annual Translational Stem Cell Research Conference: Behavioral epigenetics : Second annual pepducin science"
  • "Annals meeting reports NYSCF Fifth Annual Translational Stem Cell Research Conference: Behavioral epigenetics : Second annual pepducin science"@en

workExample

http://schema.org/workExample